[1]
C. B. Prasad, D. Mahendru, G. Dahiwal, J. B. Gupta, and J. J. Nellisserry, “Empagliflozin, Linagliptin, and Metformin in a triple fixed-dose combination for individuals with type 2 diabetes”, Med. res. chronicles, vol. 9, no. 2, pp. 99-106, Apr. 2022.